The long-term impact of sustained exposure-reducing interventions (represented by a decrease in density of female anophelines). by Azra C. Ghani (160248)

List of Included studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

The search strategy in three databases. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

NIH score. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

List of excluded studies. by Zahra Tajik (20752452)

“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”

cAMP and PKA/AKAP1 decrease mobility and promote mitochondrial translocation of Drp1. by Ronald A. Merrill (224222)

Contaminant levels (ng/g wt) in the sera of obese JCR rats treated with vehicle (V) or high dose (H) NCM with (E) or without (W) co-exposure to ethanol. by Ryan J. Mailloux (50825)

Mean plasma concentration-time profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Subjects:

GSPs decrease cell viability and induce cell death of HNSCC cells. by Ram Prasad (305524)

SAA and saaHDL decrease adiponectin secretion by hMADS adipocytes. by Aurélie Faty (169741)

Reduction of GCC signaling decreases membrane-associated TJPs in IEC monolayer. by Xiaonan Han (231176)

Modafinil treatment prevents METH-induced decrease in DAT immunoreactivity in the striatum. by Mariana Raineri (304307)

“…Values are expressed as mean ± SEM. Kruskal Wallis ANOVA on ranks, different letters: p<0.05.…”

LPS dose-dependently decreases T cell proliferative response to OKT3. by Fanny Poujol (834338)

N100 amplitude decrease during 1 Hz-rTMS. by Christian Helfrich (297785)

“…Electrodes C3, CP3’ and CP5’ were pooled. <i>Left</i>: TMS-evoked N100 amplitude continuously decreased during the stimuli 1–500. …”

FLCN-deficiency leads to decreased Rho activity in sub-confluent cells and delays in wound closure. by Doug A. Medvetz (300145)

“…The FLCN-null UOK257 cells had a 2.5-fold decrease in active Rho levels (Rho GTP) compared to the FLCN re-expressing UOK257-2 cells (n = 3, p<0.05). …”

Trust levels before and after the COVID-19 pandemic (n = 10,000). by Alain Abi-Rizk (8549358)

Expression of HCMV US proteins by MSC decreases PBMNC proliferation and correlates with the levels of HLA-I. by Melisa A. Soland (162129)

Fig 5 - by Kellie J. Walters (10451329)

Subjects:

Knockdown of Dp71 expression decreases the proliferation of PC12 cells. by Marcela Villarreal-Silva (208792)

HDAC inhibitor reduced the expression of SGLT1 and decreased glucose uptake. by Chia-Wei Chou (354261)